{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:54:16Z","timestamp":1783338856677,"version":"3.54.6"},"reference-count":25,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2017.7507","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T08:50:51Z","timestamp":1512031851000},"source":"Crossref","is-referenced-by-count":2,"title":["Intra\u2011arterial interventional therapy for inoperable local advanced breast cancer: A retrospective study"],"prefix":"10.3892","author":[{"given":"Jing","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cibo","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, People's Liberation Army Army General Hospital, Beijing 100700, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2017,11,30]]},"reference":[{"key":"key20200714002002_b1-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1524-4741.2008.00618.x","article-title":"Global health inequalities and breast cancer: An impending public health problem for developing countries","volume":"14","author":"Igene","year":"2008","journal-title":"Breast J"},{"key":"key20200714002002_b2-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","article-title":"Breast cancer","volume":"365","author":"Veronesi","year":"2005","journal-title":"Lancet"},{"key":"key20200714002002_b3-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"key20200714002002_b4-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/jnci\/djn330","article-title":"Increasing breast cancer incidence in China: The numbers add up","volume":"100","author":"Ziegler","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"key20200714002002_b5-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"448","DOI":"10.6004\/jnccn.2015.0060","article-title":"Breast Cancer Version 2. 2015","volume":"13","author":"Gradishar","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"key20200714002002_b6-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"key20200714002002_b7-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s10549-013-2500-7","article-title":"Trends in breast cancer incidence and mortality in the United States: Implications of prevention","volume":"138","author":"Toriola","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"key20200714002002_b8-ol-0-0-7507","first-page":"1697","volume-title":"Cancer, Principle and Practice of Oncology","author":"Winer","year":"2001","edition":"6th"},{"key":"key20200714002002_b9-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","article-title":"Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: New perspectives 2006","volume":"18","author":"Kaufmann","year":"2007","journal-title":"Ann Oncol"},{"key":"key20200714002002_b10-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1158\/0008-5472.CAN-03-1957","article-title":"Microvessel density as a prognostic factor in women with breast cancer: A systematic review of the literature and meta-analysis","volume":"64","author":"Uzzan","year":"2004","journal-title":"Cancer Res"},{"key":"key20200714002002_b11-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1002\/cncr.20298","article-title":"Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26\u201328, 2003, Philadelphia, Pennsylvania","volume":"100","author":"Schwartz","year":"2004","journal-title":"Cancer"},{"key":"key20200714002002_b12-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.6004\/jnccn.2009.0070","article-title":"NCCN clinical practice guidelines in oncology: Breast cancer screening and diagnosis","volume":"7","author":"Bevers","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"key":"key20200714002002_b13-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1002\/cncr.24901","article-title":"Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer: Long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099","volume":"116","author":"Alvarez","year":"2010","journal-title":"Cancer"},{"key":"key20200714002002_b14-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3747\/co.v15i6.242","article-title":"Residual cancer burden in locally advanced breast cancer: A superior tool","volume":"15","author":"Nahleh","year":"2008","journal-title":"Curr Oncol"},{"key":"key20200714002002_b15-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1038\/sj.bjc.6603096","article-title":"Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single center phase III trial","volume":"94","author":"Pacilio","year":"2006","journal-title":"Br J Cancer"},{"key":"key20200714002002_b16-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1259\/0007-1285-65-771-248","article-title":"Neoadjuvant intra-arterial chemotherapy in inflammatory carcinoma of the breast","volume":"65","author":"Bilbao","year":"1992","journal-title":"Br J Radiol"},{"key":"key20200714002002_b17-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/00000421-200104000-00017","article-title":"Intraarterial infusion chemotherapy and radiotherapy with or without surgery for patients with locally advanced or recurrent breast cancer","volume":"24","author":"Murakami","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"key20200714002002_b18-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0720-048X(01)00417-X","article-title":"Preoperative transcatheter arterial infusion chemotherapy for locally advanced breast cancer (stage IIIb) for down-staging and increase of resectability","volume":"43","author":"Kitagawa","year":"2002","journal-title":"Eur J Radiol"},{"key":"key20200714002002_b19-ol-0-0-7507","first-page":"761","article-title":"Intra-arterial chemotherapy: A safe treatment for elderly patients with locally advanced breast cancer","volume":"20","author":"Pacetti","year":"2006","journal-title":"In Vivo"},{"key":"key20200714002002_b20-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11604-010-0547-5","article-title":"Clinical efficacy and value of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer","volume":"29","author":"Shimamoto","year":"2011","journal-title":"Jpn J Radiol"},{"key":"key20200714002002_b21-ol-0-0-7507","first-page":"4339","article-title":"First-line intraarterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer","volume":"23","author":"Fiorentini","year":"2003","journal-title":"Anticancer Res"},{"key":"key20200714002002_b22-ol-0-0-7507","first-page":"20","article-title":"Neoadjuvantintraarterial chemotherapy in locally advanced breast cancer: A prospective randomized study. Osaka Breast Cancer Study Group","volume":"24","author":"Takatsuka","year":"1994","journal-title":"Jpn J Clin Oncol"},{"key":"key20200714002002_b23-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejso.2008.03.015","article-title":"Neoadjuvant chemotherapy for locally advanced breast cancer: A review of the literature and future directions","volume":"35","author":"Mathew","year":"2009","journal-title":"Eur J Surg Oncol"},{"key":"key20200714002002_b24-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1524-4741.2007.00517.x","article-title":"An update on prognosis in breast cancer patients with extensive axillary disease","volume":"14","author":"Hoehne","year":"2008","journal-title":"Breast J"},{"key":"key20200714002002_b25-ol-0-0-7507","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1471-2407-9-375","article-title":"Retrospective analysis of 119 Chinese noninflammatory locally advanced breast cancer cases treated with intravenous combination of vinorelbine and epirubicin as a neoadjuvant chemotherapy: A median follow-up of 63.4 months","volume":"9","author":"Huang","year":"2009","journal-title":"BMC Cancer"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:51:59Z","timestamp":1594687919000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2017.7507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,30]]},"references-count":25,"URL":"https:\/\/doi.org\/10.3892\/ol.2017.7507","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,30]]}}}